Medicare Rx Regs At OMB
This article was originally published in The Pink Sheet Daily
The White House Office of Management & Budget is reviewing the Medicare drug benefit implementing regs
You may also be interested in...
The Centers for Medicare & Medicaid Services may not issue the Medicare Modernization Act Title I and Title II final implementing regulations until after the Jan. 18 and 19 Senate confirmation hearings for HHS Secretary nominee Mike Leavitt
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.